Connect with us

International

‘Fingers Being Pointed’: Secret Service’s Explanations For Security Failures Ahead Of Trump Assassination Attempt Aren’t Adding Up

Published

12 minute read

From the Daily Caller News Foundation

By KATELYNN RICHARDSON

 

Secret Service’s explanations for the security failures surrounding the assassination attempt against former President Donald Trump at a rally on Saturday aren’t adding up, according to security experts and former Secret Service agents.

Emerging details highlight what seems to be a disconnect between local officials and Secret Service, while making it more apparent that there were major oversights. Many key questions hinge on the responsibilities delegated to local police, who U.S. Secret Service Director Kimberly Cheatle confirmed during a Monday interview with ABC News were inside the building the shooter fired from, though nobody was stationed on the rooftop.

Cheatle explained a decision was made not to put anybody on top of the building because the “sloped” roof made it unsafe, but security experts and former Secret Service agents who spoke with the Daily Caller News Foundation emphasized not having someone on the roof was a “big failure” and didn’t believe Cheatle’s explanation was sufficient.

“Let’s just say the local law enforcement officers [and] the Secret Service agree that it’s just not safe to keep someone up there for a couple of hours,” former Secret Service agent Anthony Cangelosi told the DCNF. “Then the question is, well, how do we maintain its integrity otherwise? It’s not like you just throw your hands up and say ‘can’t do that.’”

Cangelosi said there is no “justifiable reason” for failing to cover the roof, suggesting they should have found solutions like putting another platform up or getting an officer on a lift.

Peter Yachmetz, retired FBI agent and principal security consultant at Yachmetz Consulting Group, pointed out that the shooter was moving around on the “unsafe” roof prior to the incident.

“The slope didn’t affect him,” Yachmetz told the DCNF.

Law enforcement reportedly spotted the shooter on the roof 30 minutes before shots were fired, WPXI reported Monday. After the incident, a witness described watching a man climbing onto the roof and trying to warn a police officer, claiming officials responded with confusion.

“The reality is, regardless of the spin, that particular roof should have been under constant surveillance and or posted,” former secret service agent Tim Miller told the DCNF.

 

“In this particular instance, we did share support for that particular site and that the Secret Service was responsible for the inner perimeter,” Cheatle told ABC News Monday during an interview. “And then we sought assistance from our local counterparts for the outer perimeter. There was local police in that building — there was local police in the area that were responsible for the outer perimeter of the building.”

However, a local law enforcement official told The New York Times Tuesday that the local forces were in an adjacent building, not the one the shooter was firing from.

The discrepancies in their accounts only add to the uncertainties surrounding who was responsible.

CBS News reported Monday that there were three snipers stationed inside the building shooter Thomas Matthew Crooks fired from, citing a local law enforcement officer. One of the snipers saw Crooks looking through a rangefinder in the minutes before he fired and radioed command post, according to CBS News.

The Butler Township Police Department declined to confirm the report to the DCNF, stating that there is an ongoing investigation by the FBI.

Butler County Sheriff Michael Slupe declined to offer additional comments Tuesday, telling the DCNF he is “backing away from media requests for comment and opinions.”

“There are too many questions being posed that I do not have first hand knowledge of and too many fingers being pointed,” he said. “I am in charge of the Deputy Sheriffs and no other law enforcement agency. My Deputies performed their duties at their assigned areas and went above and beyond after the shooting started and ended in the their actions to help people and assist police in clearing the nearby buildings.”

Slupe previously confirmed to CNN that an armed Butler Township officer encountered Crooks before he shot at Trump, but retreated down the ladder after Crooks pointed his gun at him. He told KDKA-TV there was a security failure, but noted “there is not just one entity responsible.”

“The Secret Service plays a key role in protecting, in this case, former President Trump, but they don’t act alone,” he told the outlet. “The Secret Service receives support from local police departments.”

Pennsylvania State Police, however, did confirm they had no members “inside the building or staging in it.”

“The Pennsylvania State Police provided all resources that the United States Secret Service (USSS) requested for former President Trump’s rally in Butler on Saturday, July 13th, including approximately 30 to 40 troopers to assist with securing the inside perimeter,” Pennsylvania State Police Lieutenant Adam Reed told the DCNF. “Among PSP’s duties at the rally, the Department was not responsible for securing the building or property at AGR International.”

Reed said he could not say when an officer witnessed the shooter, as it was not a state trooper who saw him.

 

Former secret service agent Jeffrey James explained to the DCNF that protection “works in a series of concentric circles.” Typically, there is an inner circle of secret service agents, a second circle that mixes both agents and local law enforcement, and an outer ring that is largely state and local partners.

If the agent in charge of the site told a local law enforcement officer on the outer perimeter that the building is his responsibility, then anything that happens is on the officer.

“But if that agent didn’t find one of the local law enforcement partners and give very clear, direct directions…then it’s going to be the responsibility or the fault of that agent for not delegating that,” he told the DCNF.

It’s unclear what instructions the Secret Service gave to local law enforcement.

Butler County District Attorney Richard Goldinger told The Washington Post Tuesday that “Secret Service was in charge” and that “it was their responsibility to make sure that the venue and the surrounding area was secure.”

“For them to blame local law enforcement is them passing the blame when they hold the blame, in my opinion,” Goldinger told The Washington Post.

However, the Secret Service released a statement on Tuesday pushing back against assertions that they were blaming local law enforcement for the tragedy that unfolded on Saturday. “Any news suggesting the Secret Service is blaming local law enforcement for Saturday’s incident is simply not true,” the statement posted to the Secret Service’s X page said.

“I am having difficulty reconciling the answer the Director gave in her ABC interview with the official statement made on social media,” Patrick Yoes, national president of the Fraternal Order of Police, said in a press release on Tuesday. “Our goal is to provide whatever assistance the Secret Service needs to perform their mission and to do so with mutual respect, trust, and accuracy.”

A RealClearPolitics report suggested Sunday that resources were diverted away from Trump’s rally to an event where First Lady Jill Biden was speaking. Anthony Guglielmi, chief of communications for the United States Secret Service, denied this was the case.

Questions also remain about why Crooks was not taken out sooner. Cangelosi explained to the DCNF that counter-snipers can face challenges due to their distance from the target.

“With counter snipers, you’re usually so far away, it’s not usually clear whether an individual is an imminent threat, ” Cangelosi said. “It’s harder to discern. Once they discern whether that person is a threat to life or serious bodily injury, they can take the shot.”

Yachmetz questioned why drone coverage was not utilized.

“A drone strategically placed a few thousand feet above could have oversaw the entire venue,” he said.

“In my opinion, a detailed, in-depth very specific investigation must be conducted of all procedures [and] this entire matter by a non-biased outside investigative group (possibly of retired agents),” Yachmetz told the DCNF, emphasizing the investigation must not be “politically motivated.”

House Committee on Oversight and Accountability Chairman James Comer announced Monday that Cheatle would testify at a committee hearing on July 22. President Joe Biden said Sunday that he directed an “independent review” of the events.

The FBI told the DCNF it has “nothing additional to provide at this time beyond previously-issued statements.” The Bureau said Monday that it gained access to Crooks’ phone and “has conducted nearly 100 interviews of law enforcement personnel, event attendees, and other witnesses.”

Trump suffered a wound to his ear, and two were killed, including Crooks and 50-year-old ex-volunteer fire chief, Corey Comperatore. Two other attendees were also wounded the attack.

Secret Service did not respond to a request for comment.

Wallace White and Owen Klinsky contributed to this report.

Featured image credit: (Screen Capture/CSPAN)

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Daily Caller

Ex-FDA Commissioners Against Higher Vaccine Standards Took $6 Million From COVID Vaccine Makers

Published on

 

From the Daily Caller News Foundation

By Emily Kopp

Ten of the twelve former Food and Drug Administration (FDA) commissioners and acting commissioners opposed to the Trump administration’s stiffer standards for vaccines quietly disclosed ties to the pharmaceutical industry, a Daily Caller News Foundation review shows.

The FDA old guard criticized the new leadership in a Dec. 3 New England Journal of Medicine (NEJM) letter over a higher regulatory bar for vaccines, namely the expectation that most new vaccine approvals will require randomized clinical trials, arguing it could hamper the market.

“Insisting on long, expensive outcomes studies for every updated formulation would delay the arrival of better-matched vaccines when new outbreaks emerge or when additional groups of patients could benefit,” the former commissioners wrote. “Abandoning the existing methods won’t ‘elevate vaccine science’ … It will subject vaccines to a substantially higher and more subjective approval bar.”

But while the former commissioners disclosed their conflicts of interest to the medical journal — per standard practice in scientific publishing — reporters didn’t relay them to the broader public in reports in the Washington PostSTAT News and CNN.

The headlines about a bipartisan rebuke from former occupants of FDA’s highest office give the impression that the Trump administration is contravening established science, but closer inspection reveals a revolving door between pharmaceutical corporations and the agencies overseeing them.

Three of the signatories have received payments totaling $6 million from manufacturers or former manufacturers of COVID vaccines.

Scott Gottlieb has received $2.1 million in cash and stock from his position on the Pfizer board of directors, where he has advised on ethics and regulatory compliance since 2019, according to company filings to the Securities and Exchange Commission. Stephen Ostroff has received $752,310 from Pfizer in consulting fees since 2020, according to OpenPayments.

Mark McClellan has received $3.3 million from Johnson & Johnson as a member of the board of directors since 2013, SEC filings also show. McClellan also consults for the new pharmaceutical arm of the alternative investment management company Blackstone, which invested $750 million in Moderna in April 2025.

Gottlieb and McClellan did not respond to requests for comment. Ostroff could not be reached for comment.

FDA Center for Biologics Evaluation and Research Director Vinay Prasad outlined the higher standards and shared the results of an internal analysis validating 10 reports of children’s deaths following the COVID-19 vaccine in a Nov. 28 memo to staff. He called for introspection and reform at the agency.

The NEJM letter criticizes Prasad for cracking down on a practice called “immunobridging” that infers vaccine efficacy from laboratory tests rather than assessing it through real-world reductions in disease or death. The FDA under the Biden administration expanded COVID vaccines to children using this “immunobridging” technique, extrapolating vaccine efficacy from adults to children based on antibody levels.

Norman Sharpless — who in addition to previously serving as acting FDA commissioner also served as the head of the National Institutes of Health’s National Cancer Institute — consults for Tempus, a company that collaborates with COVID vaccine maker BioNTech. He has helped steer $70 million in investments in biotech through a venture capital firm he founded in November 2024. Sharpless also disclosed $26,180 in payments in 2024 from Chugai Pharmaceutical, a Japanese pharmaceutical company that markets mRNA technology among other drugs, on OpenPayments.

“I was grateful for the opportunity to serve as NCI Director and Acting FDA Commissioner in the first Trump Administration, and strongly support many of the things President Trump is trying to do in the current Administration,” Sharpless said in an email.

Margaret Hamburg, another former FDA commissioner and signatory of the NEJM letter, has since 2020 earned $2.8 million as a member of the board of Alnylam Pharmaceuticals, which markets RNA interference (RNAi) technology.

Hamburg did not respond to a message on LinkedIn.

Most signatories disclosed income from biotech companies testing experimental cancer treatments. These products could face tighter scrutiny under Prasad, a hematologist-oncologist long wary of rubberstamping pricey oncology drugs — which Prasad points out often cause some toxicity — without plausible evidence of an improvement in quality of life or survival.

The former FDA commissioners disclosed ties to Sermonix Pharmaceuticals Inc.; OncoNano Medicine; incyclix; Nucleus Radiopharma; and N-Power, a contractor that runs oncology clinical trials.

Andrew von Eschenbach, who like Sharpless formerly served both as FDA commissioner and the head of the National Cancer Institute, disclosed stock in HistoSonics, a company with investments from Bezos Expeditions and Thiel Bio seeking FDA approval for ultrasound technology targeted at tumors.

Some FDA commissioners who signed onto the letter opposing changes to vaccine approvals have ties to biotechnology investment firms, namely McClellan, who consults Arsenal Capital; Janet Woodcock, who consults RA Capital Management; and Robert Califf, who owns stock in Population Health Partners.

Califf did not respond to an email requesting comment. Woodcock did not respond to requests for comment sent to two medical research advocacy groups with Woodcock on the board. Eschenbach did not respond to a LinkedIn message.

The two signatories without pharmaceutical ties may find their judgement challenged by the FDA investigation into COVID-19 vaccine deaths, having either implemented or formally defended the Biden administration’s headlong expansion of vaccines and boosters to healthy adults and children.

David Kessler executed Biden’s vaccination policy as chief science officer at the Department of Health and Human Services, helping to secure deals for shots with Pfizer and Moderna.

Meanwhile Jane Henney chaired a National Academies of Sciences, Engineering, and Medicine report published in October 2025 that praised the performance of FDA and Centers for Disease Control and Prevention (CDC) vaccine surveillance during the pandemic — underwritten with CDC funding.

That assessment clashes with that of a Senate report, citing internal documents from FDA, finding that CDC never updated its vaccine surveillance tool “V-Safe” to include cardiac symptoms, despite naming myocarditis as a potential adverse event by October 2020, and that top officials in the Biden administration delayed warning pediatricians and other providers about the risk of myocarditis after their approval in some children in May 2021, months after Israeli health officials first detected it in February 2021. The Senate investigation named Woodcock, a signatory of the NEJM letter, as one of the FDA officials who slow-walked the warning.

Continue Reading

International

DOJ fails to fully comply with Friday deadline for Epstein files release

Published on

From The Center Square

By

The U.S. Department of Justice will not release the entirety of the federal government’s files on sex trafficker Jeffrey Epstein by the end of day Friday, failing to fully comply with a mandate from Congress.

DOJ will release several hundred thousand documents, however, Deputy Attorney General Todd Blanche said in a Fox News interview. He estimated that “several hundred thousand more” will be released “over the next couple of weeks.”

The delay, Blanche explained, is due to the significant number of redactions that the department must complete in order to protect the identifications of witnesses and victims in the files.

By failing to fully comply with a congressional edict, lawmakers would have grounds to impeach or hold U.S. Attorney General Pam Bondi in contempt of Congress.

Congress passed the Epstein Files Transparency Act on Nov. 18, which President Donald Trump signed into law the next day.

The bill, sponsored by Reps. Ro Khanna, D-Calif.; and Thomas Massie, R-Ky., requires that the U.S. Attorney General “make publicly available in a searchable and downloadable format all unclassified records, documents, communications, and investigative materials in the possession of the Department of Justice” that relate to Epstein and his close associate Ghislaine Maxwell.

“Any Justice Department official who does not comply with this law will be subject to prosecution for obstruction of justice,” Khanna vowed.

Epstein died in jail awaiting trial in 2019 and Maxwell is currently serving a 20-year prison sentence.

President Donald Trump, former president Bill Clinton, billionaire businessman Bill Gates, and dozens of other high-profile figures have received intense public scrutiny for their connections with Epstein and Maxwell.

Continue Reading

Trending

X